Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for efficacy of house dust mite rush immunotherapy in pediatric allergic rhinitis
TCTR20180722001Recruiting
- Sponsor
- Mahidol University
- Start
- Dec 2017
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of House dust mite allergen extract in allergic rhinitis (AR), sponsored by Mahidol University. Primary endpoint: Biomarkers associated with clinical efficacy. Started Dec 2017; status: recruiting.
02
Drugs
House dust mite allergen extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20180722001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180722001.